CLDI
Price
$1.63
Change
-$0.02 (-1.21%)
Updated
Sep 2, 04:54 PM (EDT)
Capitalization
8.83M
GHRS
Price
$13.94
Change
+$0.44 (+3.26%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
837.4M
65 days until earnings call
Interact to see
Advertisement

CLDI vs GHRS

Header iconCLDI vs GHRS Comparison
Open Charts CLDI vs GHRSBanner chart's image
Calidi Biotherapeutics
Price$1.63
Change-$0.02 (-1.21%)
Volume$200
Capitalization8.83M
GH Research
Price$13.94
Change+$0.44 (+3.26%)
Volume$2.28K
Capitalization837.4M
CLDI vs GHRS Comparison Chart in %
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. GHRS commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Buy and GHRS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (CLDI: $1.65 vs. GHRS: $13.50)
Brand notoriety: CLDI and GHRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 15% vs. GHRS: 29%
Market capitalization -- CLDI: $8.83M vs. GHRS: $837.4M
CLDI [@Biotechnology] is valued at $8.83M. GHRS’s [@Biotechnology] market capitalization is $837.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 0 FA rating(s) are green whileGHRS’s FA Score has 1 green FA rating(s).

  • CLDI’s FA Score: 0 green, 5 red.
  • GHRS’s FA Score: 1 green, 4 red.
According to our system of comparison, GHRS is a better buy in the long-term than CLDI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 4 TA indicator(s) are bullish while GHRS’s TA Score has 3 bullish TA indicator(s).

  • CLDI’s TA Score: 4 bullish, 6 bearish.
  • GHRS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CLDI is a better buy in the short-term than GHRS.

Price Growth

CLDI (@Biotechnology) experienced а -5.17% price change this week, while GHRS (@Biotechnology) price change was +3.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

GHRS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GHRS($837M) has a higher market cap than CLDI($8.83M). GHRS YTD gains are higher at: 92.857 vs. CLDI (-88.043). CLDI has higher annual earnings (EBITDA): -17.92M vs. GHRS (-40.66M). GHRS has more cash in the bank: 292M vs. CLDI (5.28M). GHRS has less debt than CLDI: GHRS (647K) vs CLDI (4.01M). CLDI (0) and GHRS (0) have equivalent revenues.
CLDIGHRSCLDI / GHRS
Capitalization8.83M837M1%
EBITDA-17.92M-40.66M44%
Gain YTD-88.04392.857-95%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.28M292M2%
Total Debt4.01M647K620%
TECHNICAL ANALYSIS
Technical Analysis
CLDIGHRS
RSI
ODDS (%)
Bullish Trend 5 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
54%
Bearish Trend 5 days ago
87%
Momentum
ODDS (%)
Bearish Trend 5 days ago
63%
Bullish Trend 5 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
56%
Bullish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
74%
Bullish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
88%
Advances
ODDS (%)
Bullish Trend 21 days ago
51%
Bullish Trend 6 days ago
90%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 15 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EMCAX67.250.01
+0.01%
Empiric Class A
BIECX25.46-0.07
-0.27%
Brandes International Equity C
BSCRX18.13-0.06
-0.33%
Brandes Small Cap Value R6
VSMIX27.78-0.11
-0.39%
Invesco Small Cap Value Y
AGYGX12.86-0.14
-1.08%
American Century Focused Global Gr Y

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with DYN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
-3.51%
DYN - CLDI
34%
Loosely correlated
-1.89%
VBIZF - CLDI
34%
Loosely correlated
N/A
RYTM - CLDI
30%
Poorly correlated
-1.04%
DSGN - CLDI
29%
Poorly correlated
-1.95%
RXRX - CLDI
29%
Poorly correlated
-3.39%
More

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with IVVD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
-2.46%
IVVD - GHRS
35%
Loosely correlated
-1.72%
ATAI - GHRS
34%
Loosely correlated
-1.51%
ATHE - GHRS
31%
Poorly correlated
-1.63%
MNMD - GHRS
28%
Poorly correlated
-9.20%
CLDI - GHRS
25%
Poorly correlated
-3.51%
More